Uranium specialist Cameco (NYSE:CCJ) has struggled in recent sessions as investors digested its latest financial results. While the print was somewhat downcast, the market appears to be ignoring the broader positive backdrop. Therefore, CCJ stock could be a higher-risk, higher-reward contrarian bullish opportunity. On Tuesday, the uranium producer reported a net loss of $7 million in the first quarter. The comparison to the year-ago quarter’s$119 million profit was rough. Further, sales declined to $634 mi ...